[Controlled clinical study of a new combination of a tranquilizer and an anticholinergic drug in various gastrointestinal diseases].
D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage*; D002707:Chlordiazepoxide / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003009:Clorazepate Dipotassium / Q000008:administration & dosage*; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D011413:Propantheline / Q000008:administration & dosage*; D011812:Quinuclidines / Q000008:administration & dosage
D014151:Anti-Anxiety Agents; D004338:Drug Combinations; D011812:Quinuclidines; D011413:Propantheline; D003009:Clorazepate Dipotassium; D002707:Chlordiazepoxide
Studio clinico controllato su una nuova associazione tra un ansiolitico e un anticolinergico in alcune affezioni gastroenteriche.